Trials / Completed
CompletedNCT01770886
A Phase I Study of Oral UE2343 in Healthy Subjects
A Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral UE2343 in Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 48 (actual)
- Sponsor
- University of Edinburgh · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
A randomised, double-blind, placebo-controlled, phase I study in healthy subjects. Safety, pharmacokinetic and pharmacodynamic data will be collected.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | UE2343 | Oral capsule |
| DRUG | Placebo | Oral capsule |
Timeline
- Start date
- 2013-01-01
- Primary completion
- 2013-07-01
- Completion
- 2013-07-01
- First posted
- 2013-01-18
- Last updated
- 2013-07-17
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT01770886. Inclusion in this directory is not an endorsement.